Literature DB >> 1324250

Regional cerebral blood flow after marijuana smoking.

R J Mathew1, W H Wilson, D F Humphreys, J V Lowe, K E Wiethe.   

Abstract

Regional CBF was measured with the 133Xe inhalation technique before and thrice after smoking marijuana of two strengths and placebo in 20 physically and mentally healthy male volunteers with a previous history of exposure to marijuana. They were drug-free at the time of the study. Blood pressure, pulse rate, end-tidal carbon dioxide, end-tidal carbon monoxide, and forehead skin perfusion were quantified during the CBF measurements. Blood samples were drawn for quantification of plasma levels of delta 9-tetrahydrocannabinol (THC) before and during the 2 h after smoking marijuana or placebo. Drug-induced intoxication and changes in mood were quantified with rating scales. Marijuana smoking was associated with bilateral CBF increase, which was maximal 30 min later. Greater CBF increases were seen in the frontal region and right hemisphere. No significant CBF changes were seen after placebo. Pulse rate and respiration increased significantly after marijuana but not placebo. Both marijuana and placebo smoking were associated with increased end-tidal carbon monoxide. CBF increase in both hemispheres correlated significantly with degree of intoxication, plasma levels of THC, and pulse rate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324250     DOI: 10.1038/jcbfm.1992.106

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  33 in total

Review 1.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

2.  Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study.

Authors:  Gen Kanayama; Jadwiga Rogowska; Harrison G Pope; Staci A Gruber; Deborah A Yurgelun-Todd
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

Review 3.  [Neuroimaging in substance abuse disorders].

Authors:  A de Mendelssohn; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

Review 4.  Endocannabinoids in cerebrovascular regulation.

Authors:  Zoltán Benyó; Éva Ruisanchez; Miriam Leszl-Ishiguro; Péter Sándor; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

5.  Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers.

Authors:  Jennifer T Sneider; Harrison G Pope; Marisa M Silveri; Norah S Simpson; Staci A Gruber; Deborah A Yurgelun-Todd
Journal:  Eur Neuropsychopharmacol       Date:  2008-06-20       Impact factor: 4.600

Review 6.  The endocannabinoid system as a target for modelling psychosis.

Authors:  Dagmar Koethe; Carolin Hoyer; F Markus Leweke
Journal:  Psychopharmacology (Berl)       Date:  2009-06-16       Impact factor: 4.530

Review 7.  Addictive illegal drugs: structural neuroimaging.

Authors:  S Geibprasert; M Gallucci; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

Review 8.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

9.  THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.

Authors:  David D Aguilar; Andrea Giuffrida; Daniel J Lodge
Journal:  J Psychopharmacol       Date:  2015-10-28       Impact factor: 4.153

10.  Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619.

Authors:  C J Hillard; W-Sv Ho; J Thompson; K M Gauthier; C E Wheelock; H Huang; B D Hammock
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.